Genscript Biotech Corporation (1548.HK)

HKD 11.18

(2.38%)

Operating Income Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual operating income in 2023 was -415.79 Million USD , up 5.1% from previous year.
Genscript Biotech Corporation's latest quarterly operating income in 2024 Q2 was -150.77 Million USD , up 21.97% from previous quarter.
Genscript Biotech Corporation reported an annual operating income of -438.11 Million USD in 2022, down -15.51% from previous year.
Genscript Biotech Corporation reported an annual operating income of -379.28 Million USD in 2021, down -85.43% from previous year.
Genscript Biotech Corporation reported a quarterly operating income of -222.56 Million USD for 2023 Q2, up 14.64% from previous quarter.
Genscript Biotech Corporation reported a quarterly operating income of -193.22 Million USD for 2023 Q4, up 13.19% from previous quarter.

Annual Operating Income Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Operating Income of Genscript Biotech Corporation (2023 - 2013)

Year	Operating Income	Operating Income Growth
2023	-415.79 Million USD	5.1%
2022	-438.11 Million USD	-15.51%
2021	-379.28 Million USD	-85.43%
2020	-204.54 Million USD	-55.73%
2019	-131.34 Million USD	-2670.37%
2018	5.11 Million USD	-87.09%
2017	39.58 Million USD	58.78%
2016	24.93 Million USD	128.72%
2015	10.9 Million USD	53.23%
2014	7.11 Million USD	-17.18%
2013	8.59 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-150.77 Million USD	21.97%
2023 Q2	-222.56 Million USD	14.64%
2023 Q4	-193.22 Million USD	13.19%
2023 FY	-415.79 Million USD	5.1%
2022 FY	-438.11 Million USD	-15.51%
2022 Q4	-260.74 Million USD	-47.12%
2022 Q2	-177.23 Million USD	21.91%
2021 FY	-379.28 Million USD	-85.43%
2021 Q4	-226.96 Million USD	-49.0%
2021 Q2	-152.32 Million USD	-27.1%
2020 Q2	-84.7 Million USD	6.18%
2020 FY	-204.54 Million USD	-55.73%
2020 Q4	-119.84 Million USD	-41.49%
2019 FY	-131.34 Million USD	-2670.37%
2019 Q4	-90.28 Million USD	-119.86%
2019 Q2	-41.06 Million USD	-302.08%
2018 Q4	-10.21 Million USD	-166.65%
2018 Q2	15.32 Million USD	-27.27%
2018 FY	5.11 Million USD	-87.09%
2017 Q4	21.06 Million USD	13.76%
2017 FY	39.58 Million USD	58.78%
2017 Q2	18.52 Million USD	73.85%
2016 Q2	14.28 Million USD	283.36%
2016 Q4	10.65 Million USD	-25.4%
2016 FY	24.93 Million USD	128.72%
2015 Q4	3.72 Million USD	-48.09%
2015 Q2	7.17 Million USD	141.94%
2015 FY	10.9 Million USD	53.23%
2014 Q4	2.96 Million USD	-28.5%
2014 Q2	4.14 Million USD	101.19%
2014 FY	7.11 Million USD	-17.18%
2013 Q4	2.06 Million USD	0.0%
2013 FY	8.59 Million USD	0.0%

Peer Operating Income Comparison of Genscript Biotech Corporation

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	713.551%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	146.304%